Nakao A - Search Results

1

Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer.

Nakao A, Kimata H, Imai T, Kikumori T, Teshigahara O, Nagasaka T, Goshima F, Nishiyama Y. Nakao A, et al. Ann Oncol. 2004 Jun;15(6):988-9. doi: 10.1093/annonc/mdh225. Ann Oncol. 2004. PMID: 15151960 Free article. No abstract available.

2

Clinical experiment of mutant herpes simplex virus HF10 therapy for cancer.

Nakao A, Takeda S, Shimoyama S, Kasuya H, Kimata H, Teshigahara O, Sawaki M, Kikumori T, Kodera Y, Nagasaka T, Goshima F, Nishiyama Y, Imai T. Nakao A, et al. Curr Cancer Drug Targets. 2007 Mar;7(2):169-74. doi: 10.2174/156800907780058808. Curr Cancer Drug Targets. 2007. PMID: 17346108 Clinical Trial.

3

Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer.

Sahin TT, Kasuya H, Nomura N, Shikano T, Yamamura K, Gewen T, Kanzaki A, Fujii T, Sugae T, Imai T, Nomoto S, Takeda S, Sugimoto H, Kikumori T, Kodera Y, Nishiyama Y, Nakao A. Sahin TT, et al. Among authors: nakao a. Cancer Gene Ther. 2012 Apr;19(4):229-37. doi: 10.1038/cgt.2011.80. Epub 2011 Dec 23. Cancer Gene Ther. 2012. PMID: 22193629

4

Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination models.

Shimoyama S, Goshima F, Teshigahara O, Kasuya H, Kodera Y, Nakao A, Nishiyama Y. Shimoyama S, et al. Among authors: nakao a. Hepatogastroenterology. 2007 Jun;54(76):1038-42. Hepatogastroenterology. 2007. PMID: 17629034

5

Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice.

Takakuwa H, Goshima F, Nozawa N, Yoshikawa T, Kimata H, Nakao A, Nawa A, Kurata T, Sata T, Nishiyama Y. Takakuwa H, et al. Among authors: nakao a. Arch Virol. 2003 Apr;148(4):813-25. doi: 10.1007/s00705-002-0944-x. Arch Virol. 2003. PMID: 12664303

6

Combined effects of adeno-associated virus vector and a herpes simplex virus mutant as neoplastic therapy.

Kasuya H, Mizuno M, Yoshida J, Nishiyama Y, Nomoto S, Nakao A. Kasuya H, et al. Among authors: nakao a. J Surg Oncol. 2000 Jul;74(3):214-8. doi: 10.1002/1096-9098(200007)74:3<214::aid-jso12>3.0.co;2-y. J Surg Oncol. 2000. PMID: 10951421

7

Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer.

Kasuya H, Nishiyama Y, Nomoto S, Hosono J, Takeda S, Nakao A. Kasuya H, et al. Among authors: nakao a. J Surg Oncol. 1999 Nov;72(3):136-41. doi: 10.1002/(sici)1096-9098(199911)72:3<136::aid-jso5>3.0.co;2-3. J Surg Oncol. 1999. PMID: 10562359

8

Surgical management of Cushing's syndrome.

Imai T, Kikumori T, Funahashi H, Nakao A. Imai T, et al. Among authors: nakao a. Biomed Pharmacother. 2000 Jun;54 Suppl 1:140s-145s. doi: 10.1016/s0753-3322(00)80031-1. Biomed Pharmacother. 2000. PMID: 10915011

9

Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production.

Aoki R, Kawamura T, Goshima F, Ogawa Y, Nakae S, Nakao A, Moriishi K, Nishiyama Y, Shimada S. Aoki R, et al. Among authors: nakao a. J Invest Dermatol. 2013 Sep;133(9):2170-9. doi: 10.1038/jid.2013.150. Epub 2013 Mar 25. J Invest Dermatol. 2013. PMID: 23528820 Free article.

10

Laparoscopic bilateral adrenalectomy for Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.

Imai T, Kikumori T, Shibata A, Fujiwara M, Nakao A. Imai T, et al. Among authors: nakao a. Biomed Pharmacother. 2002;56 Suppl 1:120s-125s. doi: 10.1016/s0753-3322(02)00220-2. Biomed Pharmacother. 2002. PMID: 12487267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,482 results

Search Page

Filters